CICOIRA, Mariantonietta
 Distribuzione geografica
Continente #
EU - Europa 4.750
NA - Nord America 4.687
AS - Asia 2.765
SA - Sud America 563
AF - Africa 53
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 12.830
Nazione #
US - Stati Uniti d'America 4.614
GB - Regno Unito 1.648
RU - Federazione Russa 1.438
SG - Singapore 1.222
CN - Cina 852
BR - Brasile 475
FR - Francia 324
HK - Hong Kong 287
DE - Germania 272
FI - Finlandia 239
IE - Irlanda 234
SE - Svezia 208
IT - Italia 192
VN - Vietnam 150
UA - Ucraina 99
KR - Corea 81
CA - Canada 31
AR - Argentina 27
TR - Turchia 27
IN - India 23
EC - Ecuador 20
MX - Messico 20
ID - Indonesia 18
BD - Bangladesh 17
ZA - Sudafrica 17
BE - Belgio 16
IQ - Iraq 11
NL - Olanda 11
PL - Polonia 11
AT - Austria 10
CL - Cile 10
IL - Israele 10
JP - Giappone 10
LT - Lituania 8
MA - Marocco 8
PE - Perù 8
PH - Filippine 8
CO - Colombia 7
EG - Egitto 7
KE - Kenya 7
UZ - Uzbekistan 7
AU - Australia 6
ES - Italia 6
PY - Paraguay 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
JO - Giordania 5
DO - Repubblica Dominicana 4
IR - Iran 4
RO - Romania 4
SA - Arabia Saudita 4
UY - Uruguay 4
BG - Bulgaria 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
DK - Danimarca 3
DZ - Algeria 3
OM - Oman 3
PA - Panama 3
PK - Pakistan 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
BY - Bielorussia 2
CH - Svizzera 2
DM - Dominica 2
ET - Etiopia 2
EU - Europa 2
GA - Gabon 2
GR - Grecia 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MD - Moldavia 2
MY - Malesia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BZ - Belize 1
CG - Congo 1
CU - Cuba 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
NG - Nigeria 1
NO - Norvegia 1
QA - Qatar 1
Totale 12.826
Città #
Southend 1.516
Jacksonville 810
Woodbridge 581
Singapore 510
Chandler 509
Dallas 409
Moscow 394
Ann Arbor 333
Hong Kong 287
Houston 255
Ashburn 236
Dublin 233
Beijing 157
Lawrence 121
Princeton 121
Wilmington 98
Nanjing 89
Verona 70
The Dalles 69
Los Angeles 66
Sindelfingen 66
Jinan 62
Buffalo 59
São Paulo 46
Ho Chi Minh City 38
Boardman 36
Shenyang 35
New York 34
Munich 33
Redondo Beach 33
Hebei 32
Columbus 31
Tianjin 31
Changsha 27
Milan 26
Hangzhou 24
Hanoi 22
Helsinki 22
Zhengzhou 21
Dong Ket 20
Norwalk 20
Santa Clara 20
Nanchang 19
Taiyuan 18
Brussels 16
Guangzhou 16
Ningbo 16
Fairfield 14
Taizhou 14
Brasília 13
Haikou 13
Jiaxing 13
Rio de Janeiro 13
Turku 13
Jakarta 12
Düsseldorf 10
Falkenstein 10
Fuzhou 10
Belo Horizonte 9
Chicago 9
Frankfurt am Main 9
London 9
Montreal 9
San Francisco 9
Toronto 9
Washington 9
Boston 8
Council Bluffs 8
Guayaquil 8
Lancaster 8
Lanzhou 8
Nuremberg 8
Seattle 8
Stockholm 8
Warsaw 8
Biên Hòa 7
Johannesburg 7
Tashkent 7
Tokyo 7
Auburn Hills 6
Bologna 6
Brooklyn 6
Campinas 6
Dhaka 6
Falls Church 6
Kent 6
Mexico City 6
Nairobi 6
Amman 5
Baguio City 5
Buenos Aires 5
Curitiba 5
Denver 5
Duque de Caxias 5
Fortaleza 5
Haiphong 5
Hải Dương 5
Manchester 5
Orchard Park 5
Redmond 5
Totale 8.108
Nome #
Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group 706
Aortic and mitral annular calcification are predictive of all-cause and cardiovascular mortality in patients with type 2 diabetes. 201
Cardiorenal Syndrome Type 1: Pathophysiological Crosstalk Leading to Combined Heart and Kidney Dysfunction in the Setting of Acutely Decompensated Heart Failure. 200
Aortic stiffness correlates with an increased extracellular matrix turnover in patients with dilated cardiomyopathy. 181
Aortic distensibility independently affects exercise tolerance in patients with dilated cardiomyopathy. 164
Additional value of pulmonary vein parameters in defining pseudonormalization of mitral inflow pattern. 156
Alterazioni muscolari e intolleranza allo sforzo nello scompenso cardiaco congestizio: ruolo centrale della periferia 152
Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circle. 150
Increased aortic pulse wave velocity as measured by echocardiography is strongly associated with poor prognosis in patients with heart failure. 148
Relationship between mitral regurgitation and myocardial viability after acute myocardial infarction: their impact on prognosis 147
Beta-blockers can improve survival in medically-treated patients with severe symptomatic aortic stenosis 147
A higher body mass index is associated with reduced prevalence of unstable atherosclerotic plaque: A possible explanation of the obesity paradox. 144
Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. 143
Echocardiographically Derived Pulse Wave Velocity and Diastolic Dysfunction Are Associated with an Increased Incidence of Atrial Fibrillation in Patients with Systolic Heart Failure 143
The role of angiotensin-converting enzyme polymorphism in congestive heart failure. 141
Biventricular pacing. 139
Amino-terminal propeptide of type III procollagen is associated with restrictive mitral filling pattern in patients with dilated cardiomyopathy: a possible link between diastolic dysfunction and prognosis. 139
Association of deranged adrenal steroid metabolism with anemia in chronic heart failure. 137
Aortic valve sclerosis: a marker of significant obstructive coronary artery disease in patients with chest pain? 134
Skeletal muscle mass independently predicts peak oxygen consumption and ventilatory response during exercise in noncachectic patients with chronic heart failure. 133
Body mass index, prognosis and mode of death in chronic heart failure: Results from the Valsartan Heart Failure Trial. 133
Aortic distensibility independently affects exercise tolerance in patients with dilated cardiomyopathy 132
Aortic valve sclerosis is a marker of atherosclerosis independently of traditional clinical risk factors. Analysis in 712 patients without ischemic heart disease. 127
Left Atrial Volume Provides Independent and Incremental Information Compared With Exercise Tolerance Parameters in Patients With Heart Failure and Left Ventricular Systolic Dysfunction. 126
Association of aortic valve sclerosis and coronary artery disease in patients with severe nonischemic mitral regurgitation. 126
Left atrial overload can be used to estimate mitral regurgitant volume. 123
Aortic stiffness: an old concept for new insights into the pathophysiology of functional mitral regurgitation. 123
Chronic heart failure and cardiac cachexia and links between the endocrine and immune system 122
Determinants of exercise intolerance symptoms considered non-specific for heart failure in patients with stage A and B: role of the left atrium in the transition phase to overt heart failure 119
High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients. 117
Predicting heart failure outcome from cardiac and comorbid conditions: The 3C-HF score. 115
ESPEN Guidelines on Enteral Nutrition: Cardiology and pulmonology. 114
Prognostic implications of evaluation of contractile reserve in akinetic and hypokinetic segments during low dose dobutamine echocardiography in patients with acute myocardial infarction. 114
Mitral regurgitation and dyspnoea: The expanding role of mitral effective regurgitant orifice among un-selected patients 114
Growth hormone resistance in chronic heart failure and its therapeutic implications. 112
Echocardiographic advances in hypertrophic cardiomyopathy: Three-dimensional and strain imaging echocardiography 112
Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure. 111
Fill in the Gaps of Secondary Mitral Regurgitation: a Continuum Challenge From Pathophysiology to Prognosis 111
Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients 110
Role of growth hormone in chronic heart failure: therapeutic implications 110
Ambient air pollution as a new risk factor for cardiovascular diseases: Time to take action 110
Carotid atherosclerotic plaque instability in patients with acute myocardial infarction. 109
Impact of body mass index on short-term outcome after acute myocardial infarction: does excess body weight have a paradoxical protective role? 109
Functional mitral regurgitation in patients with aortic stenosis: prevalence, clinical correlates and pathophysiological determinants: a quantitative prospective study. 108
Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia 107
Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. 107
Myocardial viability independently influences left ventricular diastolic function in the early phase after acute myocardial infarction. 106
Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy. 105
Role of growth hormone in chronic heart failure 105
Growth hormone treatment in chronic heart failure: lessons from the first 99 patients 105
Inhibitors of angiotensin-converting enzyme and physical function in older women. 104
Echocardiographic determinants of mortality in patients 67 years of age with chronic heart failure 104
Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype 104
Chronic heart failure with preserved left ventricular ejection fraction: Diagnostic and prognostic value of left atrial size. 103
Mitral regurgitation, left atrial structural and functional remodelling and the effect on pulmonary haemodynamics 103
Mitral regurgitation and left ventricular diastolic dysfunction similarly affect mitral and pulmonary vein flow Doppler parameters: the advantage of end-diastolic markers. 102
Identification of High-Risk Chronic Heart Failure Patients in Clinical Practice: Role of Changes in Left Ventricular Function. 102
Relevance of Functional Mitral Regurgitation in Aortic Valve Stenosis 102
Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients. 101
Prognostic value of detection of myocardial viability using low-dose dobutamine echocardiography in infarcted patients 101
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation. 100
Uric acid and survival in chronic heart failure: validation and application in metabolic, functional and hemodynamic staging. 98
Relation of aldosterone "escape" despite angiotensin-converting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. 98
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study 96
Chronic heart failure in the very elderly: clinical status, survival and prognostic factors in 188 patients more than 70 years old 95
Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulating levels in patients with chronic heart failure. 95
Long-term prognostic value of the stenosis of the infarct-related artery and the presence of viable myocardium in akinetic ventricular regions in infarcted patients 94
Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure. 94
Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by non-linear analysis: oxygen uptake efficiency slope. 93
Outpatients electrical cardioversion of atrial fibrillation: 8 years' experience. Analysis of shock-related arrhythmias. 93
Emerging strategies for chronic heart failure: the role of gene therapy 93
Renal arterial pulsatility predicts progression of chronic kidney disease in chronic heart failure patients. 92
Determinants and prognostic value of left atrial volume in patients with dilated cardiomyopathy. 91
Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not norepinephrine or TNF-alpha 90
Prediction of mortality in chronic heart failure from peak oxygen consumption adjusted for either body weight or lean tissue. 89
Prognostic relevance of pulmonary arterial compliance in patients with chronic heart failure. 89
Heart failure and anemia: Effects on prognostic variables 87
Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration 86
Mitral and aortic valve sclerosis/calcification and carotid atherosclerosis: results from 1065 patients. 86
The influence of confounders in the analysis of mid-regional pro-atrial natriuretic peptide in patients with chronic heart failure 86
Ischemic etiology of heart failure identifies patients with more severely impaired exercise capacity. 85
Exercise Performance Is a Prognostic Indicator in Elderly Patients With Chronic Heart Failure--Application of Metabolic Exercise Cardiac Kidney Indexes Score 85
Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy. 84
Effects of ace gene insertion/deletion polymorphism on response to spironolactone in patients with chronic hearth failure. 83
Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure. 82
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 82
Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis 82
Role of clinical evaluation and functional testing in the tailored follow-up of chronic heart failure patients 81
Heart failure in women treated with adjuvant trastuzumab fro breast cancer. 81
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 81
Prognostic utlity of growth differentiation factor-15 in patients with chronic heart failure 80
Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition. 79
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 79
Severe acute left ventricular dysfunction in multiple sclerosis: a case report and review of the literature. 78
Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure 78
Identification of chronic heart failure patients with a high 12-month mortality risk using biomarkers including plasma C-terminal pro-endothelin-1. 77
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison. 77
Myocardial infarction in a young patient with a previous history of repeated thrombophlebitis: combination of factor V Leiden and prothrombin G20210A gene polymorphisms with coronary artery disease. 76
Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition. 76
Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow. 75
Totale 11.519
Categoria #
all - tutte 45.316
article - articoli 45.316
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.632


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021657 0 0 0 0 123 121 19 95 89 25 130 55
2021/2022723 78 191 18 29 17 28 10 46 23 30 66 187
2022/20231.590 143 119 192 254 156 359 13 119 157 10 46 22
2023/2024659 23 82 58 108 87 71 17 44 3 18 108 40
2024/20252.196 150 162 46 358 75 77 133 114 303 164 146 468
2025/20263.044 448 307 446 837 1.006 0 0 0 0 0 0 0
Totale 12.949